English  |  正體中文  |  简体中文  |  Total items :2823024  
Visitors :  30209550    Online Users :  873
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"hong c m"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-25 of 97  (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-09T04:21:33Z Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan Hong C.-M.; Lin Y.-Y.; Liu C.-J.; Lai Y.-Y.; Yeh S.-H.; Yang H.-C.; JIA-HORNG KAO; Hsu S.-J.; Huang Y.-H.; Yang S.-S.; Kuo H.-T.; Cheng P.-N.; Yu M.-L.; Chen P.-J.
臺大學術典藏 2022-09-09T04:21:21Z Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients with Indeterminate Phase Tseng T.-C.; Hosaka T.; Liu C.-J.; Suzuki F.; Hong C.-M.; Kumada H.; Yang W.-T.; Hsu C.-Y.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen H.-H.; JIA-HORNG KAO
臺大學術典藏 2022-06-27T06:59:39Z Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients Huang C.-T.; Hong C.-M.; Tsai Y.-J.; Sheng W.-H.; CHONG-JEN YU
臺大學術典藏 2022-04-21T06:50:07Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen, Tony Hsiu Hsi; Chen P.-J.; Kao J.-H.
臺大學術典藏 2022-03-04T06:55:01Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.; SIH-HAN LIAO; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:03Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Adhoute X.; Bourli?re M.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:02Z High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T03:24:57Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; CHI-LING CHEN; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:25Z Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response Hong C.-M.; CHUN-JEN LIU; Yeh S.-H.; Chen P.-J.
臺大學術典藏 2022-01-24T09:31:22Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patients Liu C.-H.; CHUN-JEN LIU; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏 2022-01-24T09:31:21Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H.; Chen Y.-S.; Wang S.-S.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:21Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:19Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H.; Sun H.-Y.; CHUN-JEN LIU; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:18Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; CHUN-JEN LIU; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:17Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Liu C.-H.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:13Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection Liu C.-H.; Su T.-H.; CHUN-JEN LIU; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:12Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.; Liao S.-H.; Hong C.-M.; CHUN-JEN LIU; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourli?re M.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:12Z High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C.; CHUN-JEN LIU; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:06Z Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; CHUN-JEN LIU
臺大學術典藏 2022-01-24T09:30:58Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C.; CHUN-JEN LIU; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H.
臺大學術典藏 2022-01-24T09:30:52Z Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan Hong C.-M.; Lin Y.-Y.; CHUN-JEN LIU; Lai Y.-Y.; Yeh S.-H.; Yang H.-C.; Kao J.-H.; Hsu S.-J.; Huang Y.-H.; Yang S.-S.; Kuo H.-T.; Cheng P.-N.; Yu M.-L.; Chen P.-J.
臺大學術典藏 2021-09-04T05:17:12Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patients Liu C.-H.; Liu C.-J.; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; JIA-HORNG KAO; Chen D.-S.; Chen P.-J.
臺大學術典藏 2021-09-04T05:17:10Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:17:09Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:17:06Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO

Showing items 1-25 of 97  (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page